SEC Form 4 · accession 0001140361-15-026178
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Richard
Director
Period of report
Jun 29, 2015
Accepted (ET)
Jul 1, 2015 · 1:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 29, 2015 | S | 4,923 | $32.76 | D | 23,577 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.54 to $32.965, inclusive.